New

Chrome Plugin Live! Redefine the way you read FinTwit 🚀 Install Now

You have successfully sign out
Loading...
Shape
Nkarta, Inc.
NKTX
Shape
US Flag

NASDAQ

Unprofitable

EPS improving

Unprofitable

EPS improving

238M

Biotechnology

Next Earning date - 14 Nov 2024

238M

Biotechnology

Next Earning date - 14 Nov 2024

3.38USD
Shape0.04 ( 1.35%)
Market Open
favorite-chart

Relative Strenght

54
favorite-chart

Volume Buzz

-57%
favorite-chart

Earning Acce

No
favorite-chart

Dist 52w H.

79%

Quote Panel

Shape
Updated October 28, 2024
1W -18.99 % 1M -25.44 % 3M -49.63 % 1Y 66.01 %

Key Metrics

Shape
  • Market Cap

    238.14M


  • Shares Outstanding

    70.56M


  • Share in Float

    42.86M


  • Dividende

    0


  • Earning Date

    14 Nov 2024


  • Price Target

    3.375


  • Average Volume

    583306


  • Beta

    0.811


  • Range

    1.86-16.24


  • Industry

    Biotechnology


  • Website

    https://www.nkartatx.com


  • Sector

    Healthcare


Fundamentals

Shape

N/A

P/E Ratio

22.82x

P/S Ratio

0.55x

P/B Ratio

0.2

Debt/Equity

-1023.6%

Net Margin

$-2.0

EPS

How NKTX compares to sector?

P/E Ratio

Relative Strength

Shape

NKTX

Sector

loading...

Top 5 RS in Group

Symbol

Company

RS

5-Day Perf.

Forecast

Shape
0

$1.72

Shape-404%

2025-EPS

0

Analyst rating

No Data Available

Last analyst upgrade/downgrade

Rodman & Renshaw

initialise

Previous: Not converted

2024-10-09

Now: Buy

Raymond James

upgrade

Previous: Outperform

2024-08-14

Now: Strong Buy

Raymond James

downgrade

Previous: Strong Buy

2024-03-22

Now: Outperform

Raymond James

upgrade

Previous: Not converted

2023-10-17

Now: Strong Buy

Earnings GrowthShape

status-upYoY

Current

Estimates

Q3.22

arrow
arrow

N/A

-0.58
vs -0.68

Q4.22

arrow
arrow

N/A

-0.67
vs -0.69

Q1.23

arrow
arrow

N/A

-0.63
vs -0.63

Q2.23

arrow
arrow

N/A

-0.68
vs -0.48

Q3.23

arrow
arrow

N/A

-0.52
vs -0.58

Q4.23

arrow
arrow

N/A

-0.57
vs -0.67

Q1.24

arrow
arrow

N/A

-0.58
vs -0.63

Q2.24

arrow
arrow

N/A

-0.34
vs -0.68

Q3.24

arrow
arrow

N/A

-0.37
vs -0.52

Q4.24

arrow
arrow

N/A

-0.39
vs -0.57

Sales GrowthShape

status-upYoY

Current

Estimates

Q1.22

arrow
arrow

NA

NA  vs NA

Q2.22

arrow
arrow

NA

NA  vs NA

Q3.22

arrow
arrow

NA

NA  vs NA

Q4.22

arrow
arrow

NA

NA  vs NA

Q1.23

arrow
arrow

NA

NA  vs NA

Q2.23

arrow
arrow

NA

NA  vs NA

Q3.23

arrow
arrow

NA

NA  vs NA

Q4.23

arrow
arrow

NA

10.5M  vs NA

Q1.24

arrow
arrow

NA

NA  vs NA

Q2.24

arrow
arrow

NA

NA  vs NA

Return on EquityShape

status-upQoQ

Q3.22

arrow
arrow

-7%

-0.07
vs -0.07

Q4.22

arrow
arrow

-10%

-0.10
vs -0.07

Q1.23

arrow
arrow

-8%

-0.08
vs -0.10

Q2.23

arrow
arrow

-10%

-0.10
vs -0.08

Q3.23

arrow
arrow

-9%

-0.09
vs -0.10

Q4.23

arrow
arrow

-10%

-0.10
vs -0.09

Q1.24

arrow
arrow

-6%

-0.06
vs -0.10

Q2.24

arrow
arrow

-6%

-0.06
vs -0.06

Institutionnal OwnershipShape

status-upQoQ

Q3.22

arrow
arrow

105

105
vs 120

-12%

Q4.22

arrow
arrow

123

123
vs 105

17%

Q1.23

arrow
arrow

103

103
vs 123

-16%

Q2.23

arrow
arrow

98

98
vs 103

-5%

Q3.23

arrow
arrow

85

85
vs 98

-13%

Q4.23

arrow
arrow

98

98
vs 85

15%

Q1.24

arrow
arrow

117

117
vs 98

19%

Q2.24

arrow
arrow

116

116
vs 117

-1%

Earnings Growth

Latest News